Table 3.
CircRNAs and B cells functions
| circRNA | Expression pattern | Disease | Sample | Cell line | Interaction | Signaling pathway | Function | References |
|---|---|---|---|---|---|---|---|---|
| Human studies | ||||||||
| Circ_OTUD7A | ↑ | DLBCL | 50 pairs of DLBCL tissues and ANCTs | U2932, TMD8 and OCI-Ly3 LBCL cell lines and GM12878 normal human B lymphocytes | ↓ miR-431-5p, ↑ FOXP1 | – | ∆ Circ_OTUD7A: ↓ proliferation, metastasis, ↑ cell cycle arrest and apoptosis | [147] |
| circ-APC | ↓ | DLBCL | 80 pairs of DLBCL and para-cancerous tissues, plasma samples from 27 DLBCL patients and 16 healthy controls, nude mice | SUDHL-3, U2932, TMD8, OCI-Ly3 and L428 human DLBCL cell lines and GM12878 normal human B lymphocytes | miR-888, APC, DNA demethylase TET1 | Wnt/β-catenin signaling pathway | ↑ CircCFL1: ↓ proliferation and tumor growth | [149] |
| circBCL11B | ↑ | AML |
61 patients with AML and 16 healthy samples, GEO dataset: |
– | – | – | ∆ circBCL11B: ↓ proliferation, ↑ apoptosis | [151] |
| circCDYL | ↑ | MCL |
18 patients with MCL and 17 healthy controls |
HEK293T cells and Z138 human MCL cell line | five miRNAs (hsa-miR-129-5p, hsa-miR-3163, hsa-miR-4662a-5p, hsa-miR-101-3p, and hsa-miR-186-5p), three lncRNAs (MALAT1, NEAT1, and XIST), and five mRNAs (NOTCH1, FMR1, ABCB1, TWIST1, and VEGFA) | – | ∆ circCDYL: ↓ proliferation | [152] |
| circ_0132266 | ↓ | CLL |
30 patients with CLL and 30 healthy controls |
MEC-1, JVM-3 and HEK-293 T | ↑ miR-337-3p, ↓ PML | – | ↑ circ_0132266: ↓ proliferation | [150] |
| circ_0005774 | ↑ | AML | 20 patients with AML and 20 healthy controls | HL-60 and NB4 cells | ↓ miR-192-5p, ↑ ULK1 | – | ∆ circ_0005774: ↓ proliferation and viability, ↑ apoptosis | [153] |
| circ-Smad5 | ↓ | DLBCL | – | JB6 and 293 T cell lines | – | Wnt/β-catenin/Lef1 signaling pathway | ∆ circ-Smad5: ↑ cell cycle progression and activated Wnt/β-catenin/Lef1 signaling pathway | [154] |
| circ_0009910 | ↑ | AML | 35 patients with AML and 35 healthy controls | HL-60 and MOLM-13 | ↓ miR-5195-3p and ↑ GRB10 | – | ∆ circ_0009910: ↓ proliferation and cell cycle progression, ↑ apoptosis | [155] |
| circ-CBFB | ↑ | CLL |
47 patients with CLL and 21 healthy controls |
HEK293T and MEC-1 human CLL cell line |
↓ miR-607, ↑ FZD3 |
↑ Wnt/β-catenin pathway | ∆ circ-CBFB: ↓ proliferation and cell cycle progression, ↑ apoptosis | [156] |
| Murine studies | ||||||||
| CircCFL1 | ↑ | DLBCL | female BALB/c nude mice | OCI-Ly7 and OCI-Ly3 human DLBCL cell lines | ↓ miR-107, ↑HMGB1 | – | ↑ CircCFL1, ↑ proliferation, migration, tumor volume and weight | [148] |
ANCTs, adjacent non-cancerous tissues; AML, acute myeloid leukemia; HSPC, hematopoietic stem and progenitor cell; MCL, Mantle cell lymphoma; CLL, chronic lymphocytic leukemia